FDA Approves Pfizer COVID-19 Vaccine for Teens 

The U.S. Food and Drug Administration has expanded the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine to authorize its use in adolescents 12 to 15 years of age. Phase 3 trials demonstrated 100% efficacy and robust antibody response after vaccination. Click here for more.